Emmes Appoints Peter Ronco as Chief Executive Officer

Go back to Newsroom

Emmes Appoints Peter Ronco as Chief Executive Officer

Ronco’s Global Pharmaceutical Experience Will Support the Next Chapter of Emmes’ Growth and Technology Enablement
 

Rockville, MD, September 20, 2023 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Peter Ronco has been named Chief Executive Officer, effective immediately.

Download Go back to Newsroom

Emmes Acquires Essex Management

Go back to Newsroom

Emmes Acquires Essex Management

A Technology Catalyst Enabling Innovative Clinical Research, Essex Enriches and Complements Emmes’ Services
 

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the acquisition of Essex Management.  Essex offers bioinformatics and health information technology (HIT) consulting services to government, private sector and academic organizations.
 

Download Go back to Newsroom

Emmes Opens New Office in Wilmington, North Carolina

Go back to Newsroom

Emmes Opens New Office in Wilmington, North Carolina

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the opening of a new office in Wilmington, North Carolina.
 

According to Emmes Chief Executive Officer Dr. Christine Dingivan, “Wilmington is a center for clinical research innovation, and creating this new office will encourage even more collaboration and idea-sharing among our employees in the area. We are thrilled to expand our presence in a community viewed as an incubator for the CRO industry.”

Download Go back to Newsroom

Matt Honan Joins Emmes as Vice President and Head of Corporate Development

Go back to Newsroom

Matt Honan Joins Emmes as Vice President and Head of Corporate Development

Mergers & Acquisitions (M&A) Expertise Adds Value to Emmes’ Growth  Plans

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Matt Honan has joined the company as vice president and global head of corporate development.

Download Go back to Newsroom

Wendy Buckland to Join Emmes as Chief Operating Officer

Go back to Newsroom

Wendy Buckland to Join Emmes as Chief Operating Officer

New COO Adds International Experience and Clinical Operations Depth to Emmes’ Portfolio
 

Rockville, MD, December 15, 2022 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Wendy Buckland will join the company as its chief operating officer, leading global operations.

Download Go back to Newsroom

Emmes Launches Cell and Gene Therapy Center

Go back to Newsroom

Emmes Launches Cell and Gene Therapy Center

Decades of Experience and Emerging Opportunities Led to its Creation.
 

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.

Download Go back to Newsroom
Subscribe to